| TPE | Therapeutic plasma exchange |
| TP | Therapeutic plasmapheresis |
| MG | Myasthenia gravis |
| GBS | Guillain–Barré syndrome |
| ASFA | American Society for Apheresis |
| cTPE | Centrifugal separation TPE |
| mTPE | Membrane separation TPE |
| TTP | Thrombotic thrombocytopenic purpura |
| FFP | Fresh frozen plasma |
| ICU | Intensive care unit |
| APACHE II | Acute Physiology and Chronic Health Evaluation II |
| SOFA | Sequential Organ Failure Assessment |
| CCI | Charlson Comorbidity Index |
| NMO | Neuromyelitis optica |
| GPA | Granulomatosis with polyangiitis |
| ADEM | Acute Disseminated Encephalomyelitis |
| AIHA | Autoimmune hemolytic anemia with the presence of IgG3 antibodies |
| TM | Transverse myelitis |
| TBEV | Tick-borne encephalitis virus |
| MS | Multiple sclerosis |
| HUS | Hemolytic uremic syndrome |
| RF | Respiratory failure |
| PN | Polyneuropathy of uncertain etiology |
| EPV | Effective plasma volume |
| Hct | Hematocrit |
| HAIs | Hospital-acquired infections |
| DAH | Diffuse alveolar hemorrhage |
| NMOSD | Neuromyelitis optica spectrum disorders |
| ON | Optic neuritis |
| RPGN | Rapidly progressive glomerulonephritis |
| CP | Convalescent plasma |
| ACE | Angiotensin-converting enzyme |
| ACD | Acid citrate dextrose |